LifeTech ScientificFRA:81X -0.71%96 EBITDA Margin % is 26.11% as of Dec. 2025, which is 33% below its 10-year median of 38.72. GuruFocus rates FRA:81X with a GF Score™ of 96/100 and a GF Value™ of €0.21. The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, LifeTech Scientific ranks better than 65.07% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
LifeTech Scientific EBITDA Margin % Related Terms
LifeTech Scientific EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:81X vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, LifeTech Scientific's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeTech Scientific EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where LifeTech Scientific's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeTech Scientific (FRA:81X) has a EBITDA Margin % of 26.11% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on LifeTech Scientific and its competitors. This is 33% below median its historical median of 38.72. Over the past decade, LifeTech Scientific's EBITDA Margin % has ranged from 14.88 to 60.42. According to the industry distribution chart, LifeTech Scientific ranks #285 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 34.9%.
Is LifeTech Scientific's EBITDA Margin % too high?
LifeTech Scientific's current EBITDA Margin % of 26.11% is 33% below median its 10-year median of 38.72. Over the past 10 years, this metric has ranged from a low of 14.88 to a high of 60.42. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. LifeTech Scientific's value of 26.11% is 249.3% above this industry median. Based on the distribution chart, LifeTech Scientific ranks #285 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, LifeTech Scientific ranks #285 out of 816 companies for EBITDA Margin %. This puts LifeTech Scientific in the upper half of its industry. The industry median EBITDA Margin % is 7.48. LifeTech Scientific's value of 26.11% is 249.3% above this benchmark. Historically, LifeTech Scientific's own EBITDA Margin % has ranged from 14.88 to 60.42 over the past decade. While the company's 10-year median is 38.72 vs. the industry median of 7.48, LifeTech Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeTech Scientific's current EBITDA Margin % of 26.11% is 249.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on LifeTech Scientific and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeTech Scientific's current EBITDA Margin % is 26.11%, which is 33% below median its own 10-year median of 38.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (FRA:81X) has a current EBITDA Margin % of 26.11%. The stock's GF Value™ is €0.21, compared to a current price of €0.14 — trading 33.3% below its estimated fair value. The current EBITDA Margin % is 26.11%, which is 33% below median its 10-year median of 38.72 and 249.3% above the Medical Devices & Instruments industry median of 7.48. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For LifeTech Scientific (FRA:81X), the current EBITDA Margin % is 26.11% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (FRA:81X) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of €0.14 is trading 33.3% below its estimated GF Value™ of €0.21.
Key valuation signals for FRA:81X:
EBITDA Margin %: 26.11% (33% below median its 10-year median of 38.72)
GF Value™: €0.21 vs. price of €0.14 (33.3% below fair value)
Industry Position: 249.3% above the Medical Devices & Instruments median (#285 of 816)
No single metric tells the full story. See the FRA:81X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score
Get the complete analysis for FRA:81X
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:81X has been successfully added to your 
